CLINICAL_TRIALS
trial_result
· 2019-10-23
Clinical Trial Update: Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps [Phase 3]
Summary
Phase 3 clinical trial of dupilumab in patients with chronic rhinosinusitis with nasal polyps completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23